Name (Synonyms) | Correlation | |
---|---|---|
drug1097 | QFR Wiki | 1.00 |
drug77 | Angiography Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D023921 | Coronary Stenosis NIH | 1.00 |
D007511 | Ischemia NIH | 0.71 |
D003327 | Coronary Disease NIH | 0.58 |
D003324 | Coronary Artery Disease NIH | 0.58 |
D009203 | Myocardial Ischemia NIH | 0.45 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0005145 | Coronary artery stenosis HPO | 1.00 |
HP:0001677 | Coronary artery atherosclerosis HPO | 0.58 |
HP:0001658 | Myocardial infarction HPO | 0.50 |
There is one clinical trial.
The purpose of this study is to investigate if a brief online-delivered cognitive-behavioral intervention can reduce the degree of dysfunctional worry related to the Covid-19 pandemic, compared to a wait-list control condition.
Description: A 7-item self-rated scale to assess symtom severity of worry. Total score ranging from 0 to 21. Effects will be expressed as the change from baseline to last post-treatment value (Week 0-Week 3) period. Effects will also be assessed at one month and one year post-treatment.
Measure: • Covid-19-adapted version of the self-rated Generalized Anxiety Disorder Scale-7 (GAD-7) Time: Basline (week 0), during treatment (week 1 and week 2), post treatment (week 3), at one-month after treatment and also one year follow up.Description: A 9-item self-rated scale to assess symtoms of depression.Total score ranging from 0 to 54.
Measure: Montgomery Åsberg Depression Rating Scale - Self report (MADRS-S) Time: Baseline (week 0), post treatment (week 3), at one-month after treatment and also one year follow up.Description: A 5-item self-rated scale adapted to measure impact of the Covid-19 pandemic on work and social functioning. Total score ranging from 0 to 40.
Measure: Adapted Covid-19 version of the Work and Social Adjustment Scale (WSAS) Time: Basline (week 0), during treatment (week 1 and week 2), post treatment (week 3), at one-month after treatment and also one year follow up.Description: A 7-item self-rated scale to asess severity of insomnia symtoms. Total score ranging from 0 to 28.
Measure: Insomnia Severity Index (ISI) Time: Baseline (week 0), post treatment (week 3), at one-month after treatment and also one year follow up.Description: A self-rated scale to assess Coronavirus/covid-19 health/exposure status, life changes, changes in daily behaviors, impact on emotions/worries, changes in media use past two weeks and changes in substance use due to coronavirus/covid-19 crisis. The scale has bees translated to Swedish and adopted to a Swedish context.
Measure: Adapted Swedish version of the CoRonavIruS Health Impact Survey (CRISIS) Time: Baseline (week 0), post treatment (week 3), at one-month after treatment and also one year follow up.Description: A 12-item self-rated scale to assess intolerance of uncertainty. Total score ranging from 12 to 60.
Measure: Intolerance of uncertainty Scale (IUS) Time: Baseline (week 0), post treatment (week 3), at one-month after treatment and also one year follow up.Description: A self-rated scale to assess treamtent satisfaction.
Measure: Patient Satisfaction Questionnaire (PSQ) Time: Post treatment (week 3)Description: A self-rated questionnaire with free text options to assess adverse events du to the intervention.
Measure: Adverse events (AE) Time: Post treatment (week 3)